Not yet recruiting
A Study of LY3484356 in Women With Breast Cancer Before Having Surgery (EMBER-2)
J2J-MC-JZLB - ClinicalTrials.gov - NCT04647487
The purpose for this study is to see if the study drug, LY3484356, is safe and to determine what effects it has on breast cancer in participants with Estrogen Receptor Positive (ER+), HER2 Negative (HER2-) early stage (stage I-III) breast cancer, when given prior to surgery.
How long will I be in the trial?
Participation in this study could last up to 2.5 months.
Not yet recruiting
A Study of LY3484356 in Women With Breast Cancer Before Having Surgery (EMBER-2)
J2J-MC-JZLB - ClinicalTrials.gov - NCT04647487
The purpose for this study is to see if the study drug, LY3484356, is safe and to determine what effects it has on breast cancer in participants with Estrogen Receptor Positive (ER+), HER2 Negative (HER2-) early stage (stage I-III) breast cancer, when given prior to surgery.
How long will I be in the trial?
Participation in this study could last up to 2.5 months.
Key Requirements
Age :
18+
Sex:
Female
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
Female
Participants must
Participants must have estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer
Participants must be able to swallow capsules
Participants must be willing to be available for the duration of the study and are willing to follow study procedures
Participants must NOT
Participants must not be pregnant or breastfeeding
Participants must not plan to receive other treatment for breast cancer during study
Participants must not have major surgery within 28 days of starting study treatment
Trial Summary
Conditions the trial is for
Non-Metastatic Breast Cancer
What the trial is testing?
LY3484356
Could I receive a Placebo?
no
Enrollment Goal
60
Trial Dates
March 2021 - March 2022
Trial Phase
1
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
Female
Participants must
Participants must have estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer
Participants must be able to swallow capsules
Participants must be willing to be available for the duration of the study and are willing to follow study procedures
Participants must NOT
Participants must not be pregnant or breastfeeding
Participants must not plan to receive other treatment for breast cancer during study
Participants must not have major surgery within 28 days of starting study treatment
Trial Summary
Conditions the trial is for
Non-Metastatic Breast Cancer
What the trial is testing?
LY3484356
Could I receive a Placebo?
no
Enrollment Goal
60
Trial Dates
March 2021 - March 2022
Trial Phase
1
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Non-Metastatic Breast Cancer Resources
